Suppr超能文献

原发性肝癌与乙型肝炎病毒标志物(作者译)

[Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].

作者信息

Pedreira J D, Vargas V, Vilaseca J, Esteban R, Hernández-Sánchez J M, Guardia J, Bacardi R

出版信息

Med Clin (Barc). 1980 Jun 25;75(2):58-60.

PMID:6249978
Abstract

Association of primary liver carcinoma with virus of type B hepatitis has been demonstrated around the world, especially in African and Asian countries where high titles for surface antigen of B hepatitis (HBsAg) have been found. Presence of viral markers of B hepatitis has been studied in a group of 34 patients with primary liver carcinoma, in 139 cirrhotic patients, and in 100 normal individuals. Positive titles of HBsAg or of antibodies against "core" antigen (anti-HBc) without evidence of antibodies against HBsAg (anti-HBs) were considered as positive markers for virus B infection. Percentages of positive markers in the series studied were as follows: 52% in the cases of primary liver carcinoma, 38% in the cirrhotic cases, and 5% in the control subjects. There is a significant difference in relation to the incidence of viral markers between patients with liver carcinoma and normal controls. A possible role of the virus of B hepatitis in the pathogenesis of primary liver carcinoma could be suggested on the basis of these results.

摘要

原发性肝癌与乙型肝炎病毒的关联在世界各地均有证实,尤其是在非洲和亚洲国家,这些地区发现了高比例的乙型肝炎表面抗原(HBsAg)。对34例原发性肝癌患者、139例肝硬化患者和100名正常个体进行了乙型肝炎病毒标志物检测。HBsAg阳性或抗“核心”抗原抗体(抗-HBc)阳性且无抗-HBs抗体(抗-HBs)证据被视为乙型肝炎病毒感染的阳性标志物。在所研究的系列中,阳性标志物的百分比分别为:原发性肝癌患者中为52%,肝硬化患者中为38%,对照组中为5%。肝癌患者与正常对照组之间病毒标志物的发生率存在显著差异。基于这些结果,可以推测乙型肝炎病毒在原发性肝癌发病机制中可能发挥的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验